SMI-31 Immunoreactivity in inclusion body myositis
β Scribed by Simone Spuler; Andrew G. Engel
- Publisher
- John Wiley and Sons
- Year
- 1997
- Tongue
- English
- Weight
- 140 KB
- Volume
- 42
- Category
- Article
- ISSN
- 0364-5134
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Muscle phosphorus magnetic resonance spectroscopy was used to study oxidative metabolism at rest and during recovery from exercise in 7 patients with sporadic inclusion body myositis (s-IBM), compared with normal controls (n = 8) and mitochondrial myopathies (n = 20). At rest, 6/7 patients had eleva
Sporadic inclusion body myositis (S-IBM) is a progressive, acquired disease of unknown etiology. Prior studies have suggested neurogenic involvement based on electrophysiologic data, although the biopsy is compatible with a myopathic process. Quantitative electrophysiologic studies were performed in
A 10-year retrospective review was conducted to ascertain the prevalence of inclusion body myositis (IBM) in Western Australia. Seventeen patients with sporadic IBM aged 45-90 years were identified and the prevalence of IBM was calculated to be 9.3 Γ 10 -6 . The prevalence was higher in men (10.9 Γ